Published online Sep 6, 2021. doi: 10.12998/wjcc.v9.i25.7512
Peer-review started: February 8, 2021
First decision: June 7, 2021
Revised: June 9, 2021
Accepted: August 4, 2021
Article in press: August 4, 2021
Published online: September 6, 2021
Processing time: 204 Days and 1.4 Hours
The auditory brainstem implant (ABI) is a significant treatment to restore hearing sensations for neurofibromatosis type 2 (NF2) patients. However, there is no ideal method in assisting the placement of ABIs. In this case series, intraoperative cochlear nucleus mapping was performed in awake craniotomy to help guide the placement of the electrode array.
We applied the asleep-awake-asleep technique for awake craniotomy and hearing test via the retrosigmoid approach for acoustic neuroma resections and ABIs, using mechanical ventilation with a laryngeal mask during the asleep phases, utilizing a ropivacaine-based regional anesthesia, and sevoflurane combined with propofol/remifentanil as the sedative/analgesic agents in four NF2 patients. ABI electrode arrays were placed in the awake phase with successful intraoperative hearing tests in three patients. There was one uncooperative patient whose awake hearing test needed to be aborted. In all cases, tumor resection and ABI were performed safely. Satisfactory electrode effectiveness was achieved in awake ABI placement.
This case series suggests that awake craniotomy with an intraoperative hearing test for ABI placement is safe and well tolerated. Awake craniotomy is beneficial for improving the accuracy of ABI electrode placement and meanwhile reduces non-auditory side effects.
Core Tip: The auditory brainstem implant (ABI) is a significantly beneficial treatment to restore hearing sensations for neurofibromatosis type 2 (NF2) patients. However, there is no ideal method in assisting the placement of ABI. The asleep-awake-asleep technique was applied for awake craniotomy and hearing test via the retrosigmoid approach for acoustic neuromas resections and ABI in four NF2 patients. ABI ele
